ADXN
Addex Therapeutics Ltd.
$5.89
+0.00 (+0.00%)
At close · Jul 9
Market Cap
$8.03M
Shares
1,265,844
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.89
Open$5.89
Day$5.89–5.89
52W$5.41–12.05
Avg vol 30d4K
Short int2K · 0.1% float · 1.0d
Short vol88%
Last earningsSep 30, 2025
DataFeb 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.57
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−22%
below
Price vs 50-day avg
−9%
below
RSI (14)
43
neutral
MACD trend
Negative
52-week position
7%
near low
Momentum
relative strength
1-month return
−5%
trailing
6-month return
−28%
trailing
YTD return
−24%
this year
Relative strength
−37%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $8 — 200d above 50d
Institutional flow
Distributing
-20% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.12% of float · ▲ +12.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
4 holders — mid 2-yr range
Squeeze score
35
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
84%
annualized · 1-yr
Max drawdown
−48%
past year
ATR
6.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−22%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
43
Neutral
MACD trend
Negative
Bearish
52-week position
7%
Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $6 › 200d $8 — 200d above 50d
Institutional flow
Distributing
-20% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.12% of float · ▲ +12.3% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
4 holders — mid 2-yr range
Price context
position in its 52-week range
52-wk low $5
Now $6 · 7%
52-wk high $12
vs 200-day avg -22%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ADXN
this stock
Addex Therapeutics Ltd.
|
$8.03M | -23.7% | — | — | 0.1% |
|
ONC
BeOne Medicines Ltd.
|
$437.67B | -0.6% | +22179.2% | 890.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +9.5% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.03B | -14.0% | +20.8% | 16.3 | 3.3% |
|
ARGX
Argenx SE
|
$54.85B | +8.2% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
4
- % held
- 0.0%
- Net QoQ
- -155 sh
- Top holder
- MORGAN STANLEY
Held
Float
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ADXN | +3.0% | -5.5% | -28.3% | +3.3% | -23.7% |
| SPY | +0.8% | +2.0% | +8.9% | +0.7% | +10.2% |
| vs SPY | +2.2% | -7.5% | -37.2% | +2.7% | -33.9% |